
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14930447
[patent_doc_number] => 20190300861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => METABOLICALLY COMPETENT CELLS, METHODS OF MAKING, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/315675
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315675
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315675 | Metabolically competent cells, methods of making, and uses thereof | Jul 6, 2017 | Issued |
Array
(
[id] => 14342909
[patent_doc_number] => 20190153427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => DETERMINATION OF RNA IN BLOOD OR OTHER FLUIDS
[patent_app_type] => utility
[patent_app_number] => 16/315194
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3867
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315194
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315194 | DETERMINATION OF RNA IN BLOOD OR OTHER FLUIDS | Jul 6, 2017 | Abandoned |
Array
(
[id] => 16016083
[patent_doc_number] => 20200182884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES
[patent_app_type] => utility
[patent_app_number] => 16/312959
[patent_app_country] => US
[patent_app_date] => 2017-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67917
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -139
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312959
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/312959 | METHOD OF IDENTIFYING PEPTIDE EPITOPES, MOLECULES THAT BIND SUCH EPITOPES AND RELATED USES | Jun 26, 2017 | Abandoned |
Array
(
[id] => 12794956
[patent_doc_number] => 20180156821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-07
[patent_title] => TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS
[patent_app_type] => utility
[patent_app_number] => 15/632926
[patent_app_country] => US
[patent_app_date] => 2017-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23277
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15632926
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/632926 | TRANSCRIPTOMIC BIOMARKER OF MYOCARDITIS | Jun 25, 2017 | Abandoned |
Array
(
[id] => 11994300
[patent_doc_number] => 20170298455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-19
[patent_title] => 'COMPOSITION AND METHOD FOR IMAGING STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/631124
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9785
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15631124
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/631124 | Composition and method for imaging stem cells | Jun 22, 2017 | Issued |
Array
(
[id] => 14655621
[patent_doc_number] => 20190234939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-01
[patent_title] => Juvenile Atopic Dermatitis Models
[patent_app_type] => utility
[patent_app_number] => 16/311378
[patent_app_country] => US
[patent_app_date] => 2017-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24302
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311378 | Juvenile atopic dermatitis models | Jun 22, 2017 | Issued |
Array
(
[id] => 14535265
[patent_doc_number] => 20190203254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-04
[patent_title] => CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/322545
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11037
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322545 | CORTICAL NEURON CELL MODEL OF ALZHEIMER'S DISEASE BASED ON BMI1 DEFICIENCY, AND USES THEREOF | Jun 13, 2017 | Abandoned |
Array
(
[id] => 14310409
[patent_doc_number] => 20190144908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => HIGH CELL DENSITY ANAEROBIC FERMENTATION FOR PROTEIN EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 16/308267
[patent_app_country] => US
[patent_app_date] => 2017-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6191
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308267
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/308267 | HIGH CELL DENSITY ANAEROBIC FERMENTATION FOR PROTEIN EXPRESSION | Jun 8, 2017 | Abandoned |
Array
(
[id] => 14930449
[patent_doc_number] => 20190300862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => Herpesvirus with Modified Glycoprotein H for Propagation in a Cell
[patent_app_type] => utility
[patent_app_number] => 16/307708
[patent_app_country] => US
[patent_app_date] => 2017-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13547
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16307708
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/307708 | Herpesvirus with Modified Glycoprotein H for Propagation in a Cell | Jun 7, 2017 | Pending |
Array
(
[id] => 11979615
[patent_doc_number] => 20170283769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-05
[patent_title] => 'Modified Cells Evoking Reduced Immunogenic Responses'
[patent_app_type] => utility
[patent_app_number] => 15/616787
[patent_app_country] => US
[patent_app_date] => 2017-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10018
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15616787
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/616787 | Modified Cells Evoking Reduced Immunogenic Responses | Jun 6, 2017 | Abandoned |
Array
(
[id] => 12580776
[patent_doc_number] => 20180085421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-29
[patent_title] => Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent
[patent_app_type] => utility
[patent_app_number] => 15/609605
[patent_app_country] => US
[patent_app_date] => 2017-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8690
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15609605
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/609605 | Use of Tetraspanin-2 for Treating Diabetes and Screening an Anti-diabetic agent | May 30, 2017 | Abandoned |
Array
(
[id] => 14567421
[patent_doc_number] => 20190211317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES
[patent_app_type] => utility
[patent_app_number] => 16/305003
[patent_app_country] => US
[patent_app_date] => 2017-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 92689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16305003
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/305003 | PEPTIDES AND NANOPARTICLES FOR INTRACELLULAR DELIVERY OF GENOME-EDITING MOLECULES | May 25, 2017 | Abandoned |
Array
(
[id] => 16446034
[patent_doc_number] => 10837957
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-17
[patent_title] => In vitro model for pathological or physiologic conditions
[patent_app_type] => utility
[patent_app_number] => 15/599821
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 74
[patent_no_of_words] => 31763
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15599821
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/599821 | In vitro model for pathological or physiologic conditions | May 18, 2017 | Issued |
Array
(
[id] => 11949783
[patent_doc_number] => 20170253934
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'METHOD FOR SCREENING INDUCED PLURIPOTENT STEM CELLS'
[patent_app_type] => utility
[patent_app_number] => 15/600068
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11357
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600068 | Method for screening induced pluripotent stem cells | May 18, 2017 | Issued |
Array
(
[id] => 15130175
[patent_doc_number] => 10478524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-11-19
[patent_title] => Tissue-engineered silk organs
[patent_app_type] => utility
[patent_app_number] => 15/600351
[patent_app_country] => US
[patent_app_date] => 2017-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 27
[patent_no_of_words] => 8393
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15600351
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/600351 | Tissue-engineered silk organs | May 18, 2017 | Issued |
Array
(
[id] => 17513900
[patent_doc_number] => 11293033
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
[patent_app_type] => utility
[patent_app_number] => 16/302079
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 35
[patent_no_of_words] => 37509
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302079
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302079 | Compositions and methods for genomic integration of nucleic acids into exogenous landing pads | May 17, 2017 | Issued |
Array
(
[id] => 17800210
[patent_doc_number] => 11414491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-16
[patent_title] => Targeting PD-L1 on tumor cells
[patent_app_type] => utility
[patent_app_number] => 16/302403
[patent_app_country] => US
[patent_app_date] => 2017-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 30
[patent_no_of_words] => 18130
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16302403
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/302403 | Targeting PD-L1 on tumor cells | May 17, 2017 | Issued |
Array
(
[id] => 14306539
[patent_doc_number] => 20190142973
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A
[patent_app_type] => utility
[patent_app_number] => 16/098660
[patent_app_country] => US
[patent_app_date] => 2017-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16098660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/098660 | Engineered nucleases useful for treatment of hemophilia A | May 2, 2017 | Issued |
Array
(
[id] => 14581813
[patent_doc_number] => 20190218515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => EX VIVO BITE-ACTIVATED T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/093867
[patent_app_country] => US
[patent_app_date] => 2017-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53040
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093867
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093867 | EX VIVO BITE-ACTIVATED T CELLS | Apr 11, 2017 | Pending |
Array
(
[id] => 11758522
[patent_doc_number] => 20170205391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-20
[patent_title] => 'DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS'
[patent_app_type] => utility
[patent_app_number] => 15/478041
[patent_app_country] => US
[patent_app_date] => 2017-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 19968
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15478041
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/478041 | DATA ANALYSIS OF CELLS UNDERGOING EXCITATION CONTRACTION COUPLING AS DETECTED ON REAL-TIME CELL ANALYSIS (RTCA) INSTRUMENTS | Apr 2, 2017 | Abandoned |